Product Showcase
Explore our comprehensive portfolio of pharmaceutical products
APIs
Dimethyl Fumarate
Therapy
: Immune-Inflammatory diseases
Target
: Nrf2
CAS
: 624-49-7
MF
: C6H8O4
MW
: 144.13
Baricitinib
Therapy
: Immune-Inflammatory diseases
Target
: JAK1;JAK2
CAS
: 1187594-09-7
MF
: C16H17N7O2S
MW
: 371.42
Belumosudil Mesylate
Therapy
: Immune-Inflammatory diseases
Target
: ROCK
CAS
: 2109704-99-4
MF
: C27H28N6O5S
MW
: 548.62
Brensocatib
Therapy
: Immune-Inflammatory diseases
Target
: CTSC
CAS
: 1802148-05-5
MF
: C23H24N4O4
MW
: 420.47
Rilzabrutinib
Therapy
: Immune-Inflammatory diseases
Target
: BTK
CAS
: 1575596-29-0
MF
: C36H40FN9O3
MW
: 665.77
Delgocitinib
Therapy
: Immune-Inflammatory diseases
Target
: JAK
CAS
: 1263774-59-9
MF
: C16H18N6O
MW
: 310.35
Sebertralstat
Therapy
: Immune-Inflammatory diseases
Target
: KLKB1
CAS
: 1933514-13-6
MF
: C26H26FN5O4
MW
: 491.51
Seladelpar lysine
Therapy
: Immune-Inflammatory diseases
Target
: PPARδ
CAS
: 928821-40-3
MF
: C27H37F3N2O7S
MW
: 590.66
Elafibranor
Therapy
: Immune-Inflammatory diseases
Target
: PPAR
CAS
: 824932-88-9
MF
: C22H24O4S
MW
: 384.49
Givinostat hydrochloride
Therapy
: Immune-Inflammatory diseases
Target
: HDAC1; HDAC3
CAS
: 199657-29-9
MF
: C24H28ClN3O4
MW
: 457.96